Packages of aspirin fill the shelves of a drugstore, Tuesday, Aug. 11, 2009 in Chicago. A study suggests colon cancer patients who took aspirin reduced their risk of death from the disease by nearly 30 percent. (AP Photo/M. Spencer Green)
FDA Chief on balance between innovation and protecting the public
LISTEN
Copy and paste the HTML below to embed this audio onto your web page.
Audio player code:
Food and Drug Commissioner Margaret Hamburg speaks at the Commonwealth Club of California about her agency's work in protecting public health and promoting innovation. She discusses how science-based regulation is the keystone to these two missions.
More from MPR
- FDA question's Amgen drug for prostate cancer
February 6, 2012
- Pfizer recalls 1 million birth control packs
February 1, 2012
- Amylin's long-delayed diabetes drug gets FDA nod
January 27, 2012
- FDA detains OJ imports after finding fungicide
January 27, 2012
- Minnesota researchers on the cusp of a diabetes cure
January 17, 2012
- Excedrin, Bufferin, NoDoz and Gas-X recalled
January 9, 2012
- CDC, FDA say powdered infant formula not tainted
December 30, 2011
- FDA clears Pfizer vaccine for adults over 50
December 30, 2011
Resources